Back
Viking Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
VKTX
Viking Therapeutics, Inc.
Last Price:
$31.03
Seasonality Move:
5.75%
7 Day Trial
ALL ACCESS PASS
$
7
Viking Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Viking Therapeutics, Inc. has on average historically risen by 69.9% based on the past 10 years of stock performance.
-
Viking Therapeutics, Inc. has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Viking Therapeutics, Inc. Stock Undervalued?The current Viking Therapeutics, Inc. [VKTX] share price is $31.10. The Score for VKTX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
VKTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Viking Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Viking Therapeutics, Inc. has on average historically risen by 69.9% based on the past 10 years of stock performance.
Viking Therapeutics, Inc. Stock Rating
Sell
40
Viking Therapeutics, Inc. (VKTX)
is a Sell
Is Viking Therapeutics, Inc. overpriced?
-
Viking Therapeutics, Inc. has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Viking Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vikingtherapeutics.com
52-Week Data
52-Week High:
43.15
52-Week Low:
18.92
Prediction Charts
Market Cap:
3.6B
Price in USD:
31.10
Volume:
2.1M
Beta:
1.33
Technical Analysis
SMA50:
32.83
SMA100:
33.71
SMA200:
31.34
52-Wk Change:
-3.69%
Stock Predictions
-
Is Viking Therapeutics, Inc. stock public?Yes, Viking Therapeutics, Inc. is a publicly traded company.
-
What is the Viking Therapeutics, Inc. stock quote today?The Viking Therapeutics, Inc. stock price is 31.10 USD today.
-
How to buy Viking Therapeutics, Inc. stock online?You can buy Viking Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-2 | 28.65 | 29.92 | 30.25 | 28.55 |
| Feb-3 | 30.40 | 29.41 | 30.80 | 28.56 |
| Feb-4 | 29.53 | 29.56 | 29.66 | 28.01 |
| Feb-5 | 28.11 | 26.29 | 28.64 | 25.77 |
| Feb-6 | 27.51 | 28.44 | 28.47 | 26.89 |
| Feb-9 | 28.69 | 29.30 | 29.67 | 27.86 |
| Feb-10 | 29.10 | 28.75 | 29.70 | 28.64 |
| Feb-11 | 28.52 | 28.55 | 28.98 | 27.17 |
| Feb-12 | 33.75 | 30.49 | 34.38 | 30.18 |
| Feb-13 | 30.72 | 29.00 | 31.00 | 28.75 |
| Feb-17 | 29.37 | 30.45 | 31.19 | 28.80 |
| Feb-18 | 30.30 | 30.15 | 31.22 | 29.85 |
| Feb-19 | 29.97 | 31.10 | 31.19 | 29.72 |
| Feb-20 | 30.69 | 31.03 | 31.20 | 30.19 |
Viking Therapeutics, Inc. Earnings
Viking Therapeutics, Inc. Earnings Report: Per Share Viking Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Viking Therapeutics, Inc. Forecast Revenue Growth
Viking Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Viking Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.39 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.50 per share, and a decrease next year of $0.46 per share.
* Viking Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.